Efficacy and safety of intravenous ferric carboxymaltose versus oral iron in pregnant women with anemia: a systematic review and meta-analysis
European Journal of Clinical Pharmacology · 2026-08 · 82 (8)
DOI: 10.1007/s00228-026-04111-w ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 10.07.2026. Verfasst von Mustafa Shafeeq Ali und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Monoufia University, Monoufia, Egypt. Hauptthemen laut MEDLINE: Ferric Compounds, Maltose, Iron, Pregnancy Complications, Hematologic. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Intravenous (IV) ferric carboxymaltose represents an alternative to oral iron that enables rapid iron repletion through a single infusion, demonstrating promising efficacy and safety across diverse clinical settings. This study aims to evaluate the efficacy and safety of IV ferric carboxymaltose compared with oral iron in managing pregnancy-related anemia. MATERIALS AND METHODS: We systematically searched four databases for randomized controlled trials (RCTs) and observational cohorts comparing IV ferric carboxymaltose with oral iron in pregnant women with anemia. Randomized controlled trials and observational cohorts comparing intravenous ferric carboxymaltose with oral iron in pregnant women with anemia were included. Random-effects meta-analyses were performed using mean differences (MDs) for continuous outcomes and risk ratios (RRs) for dichotomous outcomes, each with 95% confidence intervals (CIs). RESULTS: Twelve studies (Eight RCTs and four cohorts) were included. IV ferric carboxymaltose significantly improved Hb concentrations compared with oral iron (7 RCTs & 4 Cohorts; 6,495 patients; MD = + 0.91 g/dL; 95% CI 0.30-1.51; p = 0.0035) and increased serum ferritin (5 studies; 4,420 patients; MD = + 63.8 ng/mL; 95% CI 37.3-90.4; p < 0.001). The benefit of Hb was most evident at pre-delivery (8 studies; 1,575 patients; MD = 1.22 g/dL, 95% CI [0.55-1.89], p = 0.0003) but not in the postpartum period (4 Studies, 5,141 patients; MD = 0.74, 95% CI [ -0.50-1.98], p = 0.24). Safety analyses demonstrated lower risks of drug-related adverse events (3 studies; 471 patients; RR = 0.42, 95% CI [0.19-0.91], p = 0.02) and nausea ( 3 studies; 3,284 patients; RR = 0.27, 95% CI [0.09-0.75], p = 0.012) with IV ferric carboxymaltose. CONCLUSIONS: Intravenous ferric carboxymaltose appears more effective than oral iron in improving hematologic indices in pregnant women with anemia and shows a favorable tolerability profile, including fewer drug-related adverse events and nausea. However, the findings should be interpreted cautiously, given the substantial heterogeneity across studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Monoufia University, Monoufia, Egypt.
- Faculty of Medicine, Kafr Elsheikh University, Kafr Elsheikh, Egypt.
- College of Human Medicine, Banha University, Banha, Egypt.
- Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
- Faculty of Medicine, Al-Azhar University, Cairo, Egypt. ahmedeshahat98@gmail.com.
ORCID-Profile: Ahmed Elshahat
Zitieren
APA
Ali, M. S., Elfiki, M., Elfeky, A., Ibrahim, A., Zayed, M., Sobhy, A., Ashour, M., Hendawy, A. A., Elshazly, A., El-Nemr, A. F., & Elshahat, A. (2026). Efficacy and safety of intravenous ferric carboxymaltose versus oral iron in pregnant women with anemia: a systematic review and meta-analysis. European Journal of Clinical Pharmacology, 82(8). https://doi.org/10.1007/s00228-026-04111-w
Vancouver
Ali MS, Elfiki M, Elfeky A, Ibrahim A, Zayed M, Sobhy A, et al. Efficacy and safety of intravenous ferric carboxymaltose versus oral iron in pregnant women with anemia: a systematic review and meta-analysis. European Journal of Clinical Pharmacology. 2026;82(8). doi:10.1007/s00228-026-04111-w
BibTeX
@article{Ali2026,
author = {Ali, Mustafa Shafeeq and Elfiki, Mahmoud and Elfeky, Abdalla and Ibrahim, Amr and Zayed, Mariem and Sobhy, Ahmed and Ashour, Mennatullah and Hendawy, Abdelrahman Ali and Elshazly, Abdelrahman and El-Nemr, Amira Fahmy and Elshahat, Ahmed},
title = {Efficacy and safety of intravenous ferric carboxymaltose versus oral iron in pregnant women with anemia: a systematic review and meta-analysis},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
volume = {82},
number = {8},
doi = {10.1007/s00228-026-04111-w}
}
EUVIMED